ASSET PURCHASE AGREEMENTAsset Purchase Agreement • March 8th, 2017 • U.S. Stem Cell, Inc. • Services-commercial physical & biological research • Florida
Contract Type FiledMarch 8th, 2017 Company Industry JurisdictionThis Asset Purchase Agreement (this "Agreement"), dated as of March 3, 2017, is entered into between U.S. Stem Cell, Inc., a Florida corporation ("Seller") and GACP Stem Cell Bank LLC, a Florida limited liability company ("Buyer"). Capitalized terms are defined herein or in the definitions attached hereto as Schedule A.
ASSET SALE AND LEASE AGREEMENTAsset Sale and Lease Agreement • March 8th, 2017 • U.S. Stem Cell, Inc. • Services-commercial physical & biological research • Florida
Contract Type FiledMarch 8th, 2017 Company Industry JurisdictionThis Asset Sale and Lease Agreement (this "Agreement"), is made and entered into as of this 3rd day of March, 2017 (the “Closing Date”), by and between GACP STEM CELL BANK LLC, a Florida limited liability company ("Lessor") and U.S. STEM CELL, INC., a Florida corporation ("Lessee").
CUSTOMER PURCHASE AGREEMENTCustomer Purchase Agreement • March 8th, 2017 • U.S. Stem Cell, Inc. • Services-commercial physical & biological research • Florida
Contract Type FiledMarch 8th, 2017 Company Industry JurisdictionTHIS CUSTOMER PURCHASE AGREEMENT is made and entered into as of the 3rd day of March, 2017 (the “Closing Date”), by and among GACP Stem Cell Bank LLC, a Florida limited liability company (“Buyer”) and U.S. Stem Cell, Inc., a Florida corporation (“Seller”).
NON-COMPETITION AND NON-SOLICITATION AGREEMENTNon-Competition and Non-Solicitation Agreement • March 8th, 2017 • U.S. Stem Cell, Inc. • Services-commercial physical & biological research • Florida
Contract Type FiledMarch 8th, 2017 Company Industry JurisdictionThis Non-Competition and Non-Solicitation Agreement (this “Agreement”), dated as of March 3, 2017 (the “Closing Date”), is entered into between GACP Stem Cell Bank LLC, a Florida limited liability company ("Company"), U.S. Stem Cell, Inc., a Florida corporation ("U.S. Stem Cell"), and Michael Tomas and Kristin Comella (“Key Persons”). Capitalized terms are defined herein or in the Definitions section below.